Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Blood T cell diversity associated with the prognosis of advanced non‐small cell lung carcinoma treated with first‐line pemetrexed based chemotherapy

Abstract Background The tumor microenvironment is associated with prognosis in advanced non‐small cell lung carcinoma (NSCLC). The aim of this study was to explore the relationship between blood T cell diversity and survival of patients treated with pemetrexed‐based chemotherapy for nonsquamous NSCL...

Full description

Bibliographic Details
Main Authors:	Li Qian, Zhang Zhaohui, Xu Yaping, Liu Zhentian, Liu Zhentao, Wang Qiqi, Gu Yangchun, Liu Yan'e, Yin Wencheng, Yi Fumei, Yao Yanhong, Cao Baoshan, Liang Li
Format:	Article
Language:	English
Published:	Wiley 2021-04-01
Series:	Thoracic Cancer
Subjects:	Advanced non‐small cell lung carcinoma T cell diversity tumor microenvironment
Online Access:	https://doi.org/10.1111/1759-7714.13771

Similar Items

Impact of the Pretreatment or Posttreatment NLR and PLR on the Response of First Line Chemotherapy and the Outcomes in Patients with Advanced Non-small Cell Lung Cancer
by: Fumei YI, et al.
Published: (2018-06-01)

Efficacy and Toxicity of Maintenance Pemetrexed Following Induction Treatment with Pemetrexed Plus Cisplatin for Advanced Non-small-cell Non-squamous Carcinoma of the Lung
by: Kim D. H., et al.
Published: (2015-06-01)

Landscape and dynamics of single tumor and immune cells in early and advanced‐stage lung adenocarcinoma
by: Zhencong Chen, et al.
Published: (2021-03-01)

Comprehensive Analysis of Myeloid Signature Genes in Head and Neck Squamous Cell Carcinoma to Predict the Prognosis and Immune Infiltration
by: Zhifeng Liu, et al.
Published: (2021-04-01)

Transcriptome Profiling Reveals B-Lineage Cells Contribute to the Poor Prognosis and Metastasis of Clear Cell Renal Cell Carcinoma
by: Fafen Yang, et al.
Published: (2021-08-01)

CTLA4 has a profound impact on the landscape of tumor-infiltrating lymphocytes with a high prognosis value in clear cell renal cell carcinoma (ccRCC)
by: Shiyi Liu, et al.
Published: (2020-10-01)

The oncological outcome and influence of neoadjuvant chemotherapy on the surgery in the resectable and locally advanced oral squamous cell carcinoma
by: Su X, et al.
Published: (2019-07-01)

Interactive Effects of PD-L1 Expression in Tumor and Immune Cells on Prognosis of Esophageal Squamous Cell Carcinoma: A One-Center Retrospective Cohort Study
by: Shi F, et al.
Published: (2020-07-01)

Retrospective Analysis of Risk Factors for Venous Thromboembolism  in 283 Patients with Lung Cancer during Systemic Therapy
by: Yan’e LIU, et al.
Published: (2019-07-01)

Abundance of Microvascular Endothelial Cells is Associated with Response to Chemotherapy and Prognosis in Colorectal Cancer
by: Masanori Oshi, et al.
Published: (2021-03-01)

Cisplatin-based Chemotherapy in Elderly Patients with Non-small Cell Lung Cancer
by: Jian Li, et al.
Published: (2010-03-01)

Increased Expression of SHMT2 Is Associated With Poor Prognosis and Advanced Pathological Grade in Oral Squamous Cell Carcinoma
by: Zhi-Zhong Wu, et al.
Published: (2020-10-01)

PD‐1 expression on the surface of peripheral blood CD4+ T cell and its association with the prognosis of patients with diffuse large B‐cell lymphoma
by: Wei Zhang, et al.
Published: (2016-11-01)

Stem/progenitor cell marker expression in clear cell renal cell carcinoma: a potential relationship with the immune microenvironment to be explored
by: Ju-Yoon Yoon, et al.
Published: (2020-04-01)

Influence of Immune Microenvironment on Diagnosis and Prognosis of Head and Neck Squamous Cell Carcinoma
by: Guohong Liu, et al.
Published: (2021-03-01)

Myeloid-Derived Suppressor Cells in Immune Microenvironment Promote Progression of Esophagogastric Junction Adenocarcinoma
by: Ying Wang, et al.
Published: (2021-03-01)

Identifying Hypoxia Characteristics to Stratify Prognosis and Assess the Tumor Immune Microenvironment in Renal Cell Carcinoma
by: Zhenan Zhang, et al.
Published: (2021-06-01)

Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-10-01)

Further Understanding of the Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: Implications for Prognosis
by: Denaro N, et al.
Published: (2021-05-01)

Inflammatory Cells in Diffuse Large B Cell Lymphoma
by: Roberto Tamma, et al.
Published: (2020-07-01)

Cell-in-Cell Phenomenon and Its Relationship With Tumor Microenvironment and Tumor Progression: A Review
by: Xinlong Wang, et al.
Published: (2019-12-01)

Single-cell analysis of a tumor-derived exosome signature correlates with prognosis and immunotherapy response
by: Jiani Wu, et al.
Published: (2021-09-01)

Applications of single-cell sequencing in cancer research: progress and perspectives
by: Yalan Lei, et al.
Published: (2021-06-01)

Chemotherapy and tumor microenvironment of pancreatic cancer
by: Qiaofei Liu, et al.
Published: (2017-07-01)

Perioperative chemotherapy with pemetrexed and cisplatin for pulmonary large-cell neuroendocrine carcinoma: a case report and literature review
by: Tang H, et al.
Published: (2018-05-01)

M2 macrophage infiltration into tumor islets leads to poor prognosis in non-small-cell lung cancer
by: Cao L, et al.
Published: (2019-07-01)

Immune Cell Infiltration of the Primary Tumor Microenvironment Predicted the Treatment Outcome of Chemotherapy With or Without Bevacizumab in Metastatic Colorectal Cancer Patients
by: Yixing Wang, et al.
Published: (2021-01-01)

Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments
by: Ghmkin Hassan, et al.
Published: (2020-05-01)

Retrospective Analysis of Pemetrexed-based Chemotherapy Regimens on Mid-elderly Non-Hodgkin's Lymphoma
by: WEN Tingyu, et al.
Published: (2020-02-01)

Biophysical and Biochemical Cues of Biomaterials Guide Mesenchymal Stem Cell Behaviors
by: Jianjun Li, et al.
Published: (2021-03-01)

The effect of a novel glycolysis-related gene signature on progression, prognosis and immune microenvironment of renal cell carcinoma
by: Fangshi Xu, et al.
Published: (2020-12-01)

A versatile system to record cell-cell interactions
by: Rui Tang, et al.
Published: (2020-10-01)

A Single Center, Retrospective Analysis of Prognosis in Non-small Cell Lung Cancer Patients with Peritoneal Carcinomatosis
by: Baoshan CAO, et al.
Published: (2019-03-01)

Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment
by: Hass Ralf, et al.
Published: (2012-09-01)

Disease-Associated Plasmacytoid Dendritic Cells
by: Shuang Li, et al.
Published: (2017-10-01)

Tumor Immune Microenvironment Characterization Identifies Prognosis and Immunotherapy-Related Gene Signatures in Melanoma
by: Dan Liu, et al.
Published: (2021-05-01)

Construction and Validation of an Immune Cell Signature Score to Evaluate Prognosis and Therapeutic Efficacy in Hepatocellular Carcinoma
by: Linfeng Xu, et al.
Published: (2021-09-01)

Chemotherapy in Metastatic NSCLC – New Regimens (Pemetrexed, nab-Paclitaxel)
by: Vera eHirsh, et al.
Published: (2014-07-01)

CCR7 Has Potential to Be a Prognosis Marker for Cervical Squamous Cell Carcinoma and an Index for Tumor Microenvironment Change
by: Wei-Jie Tian, et al.
Published: (2021-04-01)

Microenvironment-related gene TNFSF13B predicts poor prognosis in kidney renal clear cell carcinoma
by: Mingzhe Jiang, et al.
Published: (2020-06-01)